Cellsearch
Payments companies reported to CMS as associated with Cellsearch. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cellsearch, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cellsearch
These are the largest totals companies reported as associated with Cellsearch. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Wright | Lansdale, PA | Anatomic Pathology & Clinical Pathology | $391,521.00 |
| Mats Sanden | Pensacola, FL | Anatomic Pathology & Clinical Pathology | $67,200.00 |
| Anthony Gregg | Columbia, SC | Maternal & Fetal Medicine | $50,237.57 |
| Na Tosha Gatson | Phoenix, AZ | Neurological Surgery | $31,107.01 |
| Jonathan Zager | Tampa, FL | Surgical Oncology | $19,723.94 |
| Massimo Cristofanilli | New York, NY | Hematology & Oncology | $16,607.11 |
| Anthony Lucci | Houston, TX | Surgical Oncology | $10,336.70 |
| Binod Dhakal | Milwaukee, WI | Hematology & Oncology | $7,885.68 |
| Hans Lee | Houston, TX | Internal Medicine | $7,077.72 |
| Ehsan Malek | Buffalo, NY | Medical Oncology | $6,435.45 |
Prescribed Cellsearch?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.